{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:29:29Z","timestamp":1781620169147,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron overload is a major concern in pediatric oncology, especially among patients receiving frequent blood transfusions. Although serum ferritin (SF) is widely used as a surrogate marker, T2* magnetic resonance imaging (MRI) of the liver and heart remains the gold standard for quantifying tissue iron deposition. This study evaluated the relationship between serum ferritin levels and T2* MRI findings in pediatric cancer patients, focusing on those with ferritin levels &amp;gt;1,000\u2005\u00b5g\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included patients aged 10\u201325 years diagnosed with malignancies and followed at the Pediatric Hematology and Oncology Clinic of Adana City Training and Research Hospital between June 2023 and December 2024. The upper age limit was chosen to include adolescent and young adult patients treated under pediatric oncology protocols. Serum ferritin and C-reactive protein (CRP) levels were measured during afebrile, infection-free periods. Elevated ferritin levels concurrent with high CRP were re-evaluated to exclude inflammation-related effects. Transfusion frequency and ferritin levels were recorded at 3, 6, and 12 months. Patients with ferritin &amp;gt;1,000\u2005\u00b5g\/L underwent cardiac and hepatic T2* MRI to assess organ-level iron burden and determine the need for chelation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-eight patients (median age: 14 years; 12 females, 16 males) were analyzed. The median baseline ferritin level was 32.5\u2005\u00b5g\/L. A significant correlation was found between transfusion number and ferritin &amp;gt;1,000\u2005\u00b5g\/L within the first 3 months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.48) and for total annual transfusions (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Correlations at 3\u20136 months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.061,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.42) and 6\u201312 months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.065, r\u2009=\u20090.39) were not statistically significant. Three patients (10.7%) had ferritin &amp;gt;1,000\u2005\u00b5g\/L\u2014two with acute lymphoblastic leukemia and one with non-Hodgkin lymphoma. Among them, one underwent bone marrow transplantation, one died, and one had moderate hepatic but normal cardiac iron on T2* MRI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Iron overload is a preventable but clinically important complication in pediatric oncology. Combined monitoring with serum ferritin and T2* MRI enables early detection and timely management. Larger multicenter studies are needed to optimize screening intervals and chelation strategies in this high-risk group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1619659","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:42:13Z","timestamp":1767598933000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of iron accumulation during childhood cancer treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"\u015eule","family":"\u00c7al\u0131\u015fkan Kam\u0131\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"\u00c7il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcl","family":"Ya\u011fc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbaros \u015eahin","family":"Karag\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"B2","volume-title":"SEER Cancer Statistics Review, 1975\u20132011","author":"Howlader","year":"2013"},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MPH.0000000000000444","article-title":"Iron overload in survivors of childhood cancer","volume":"38","author":"Schempp","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorder of iron metabolisme","volume":"341","author":"Andrews","year":"1999","journal-title":"J. Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MPH.0000000000000887","article-title":"Iron overload in survivors of childhood cancer","volume":"40","author":"Trovillion","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/pbc.24705","article-title":"Iron overload in children undergoing cancer treatments","volume":"60","author":"De Ville de Goyet","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body iron metabolism and pathophysiology of iron overload","volume":"88","author":"Kohgo","year":"2008","journal-title":"Int J Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00431-007-0604-y","article-title":"What is new in iron overload?","volume":"167","author":"Vermylen","year":"2008","journal-title":"Eur J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e13846","DOI":"10.1111\/petr.13846","article-title":"Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia","volume":"24","author":"Salmi","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1399-3046.2008.00983.x","article-title":"Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Chotsampancharoen","year":"2009","journal-title":"Pediatr Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD011817","DOI":"10.1002\/14651858.CD011817.pub2","article-title":"Serum or plasma ferritin concentration as an index of iron deficiency and overload","volume":"5","author":"Garcia-Casal","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MOH.0b013e3280d2b76b","article-title":"Magnetic resonance imaging measurement of iron overload","volume":"14","author":"Wood","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/1055-9965.EPI-14-0292","article-title":"Characterization of transfusion-derived iron deposition in childhood cancer SurvivorsTransfusional iron in childhood cancer survivors","volume":"23","author":"Ruccione","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2217\/iim.13.60","article-title":"Is MRI becoming the new gold standard for diagnosing iron overload in hemochromatosis and other liver iron disorders?","volume":"5","author":"Castiella","year":"2013","journal-title":"Imaging Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.16288\/j.yczz.15-195","article-title":"Progress of iron-chelating therapy for iron overload in patients after bone marrow transplantation","volume":"37","author":"Li","year":"2015","journal-title":"Yi Chuan"},{"key":"B17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1542\/peds.111.1.91","article-title":"Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters","volume":"111","author":"Halonen","year":"2003","journal-title":"Pediatrics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ejh.12159","article-title":"Free iron catalyzes oxidative damage to hematopoietic cells\/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients","volume":"91","author":"Lu","year":"2013","journal-title":"Eur J Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.blre.2018.04.004","article-title":"Iron toxicity\u2013its effect on the bone marrow","volume":"32","author":"Isidori","year":"2018","journal-title":"Blood Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/bmt.2008.262","article-title":"Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation","volume":"42","author":"Pullarkat","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1619659\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:42:14Z","timestamp":1767598934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1619659\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":20,"alternative-id":["10.3389\/fped.2025.1619659"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1619659","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1619659"}}